These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2727279)

  • 21. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination treatment of recurring laryngeal cancer].
    Andreev VG
    Med Radiol (Mosk); 1986 Nov; 31(11):21-5. PubMed ID: 3784820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous cell carcinoma of the subglottis.
    Garas J; McGuirt WF
    Am J Otolaryngol; 2006; 27(1):1-4. PubMed ID: 16360814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oncologic surgery of the larynx after failure of radiotherapy].
    Pinilla M; González FM; Górriz C; Arellano B; Vicente J; Trinidad A
    Acta Otorrinolaringol Esp; 1998; 49(8):633-6. PubMed ID: 9951083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multidisciplinary treatment of carcinoma of the larynx].
    Yoshino K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1812-9. PubMed ID: 3592716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing tumour relapse after total laryngectomy.
    Nikolaou A; Markou K; Petridis D; Vlachtsis K; Nalbantian M; Daniilidis L
    B-ENT; 2005; 1(1):1-10. PubMed ID: 15999669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction chemotherapy and larynx preservation: is such practice useful?].
    Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
    Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure.
    Ballo MT; Garden AS; El-Naggar AK; Gillenwater AM; Morrison WH; Goepfert H; Ang KK
    Laryngoscope; 1998 May; 108(5):760-3. PubMed ID: 9591559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
    Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
    Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of low hemoglobin concentration in adjuvant radiotherapy after total laryngectomy in group of patients with laryngeal cancer].
    Milecki P; Kruk-Zagajewska A; Skowronek J
    Przegl Lek; 2005; 62(12):1447-50. PubMed ID: 16786770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of an organ conservation protocol in patients with locally advanced laryngeal tumours].
    León X; López M; García J; Quer M
    Acta Otorrinolaringol Esp; 2009; 60(3):176-85. PubMed ID: 19558903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organ preservation therapy for advanced-stage laryngeal carcinoma.
    Hoffman HT; McCulloch T; Gustin D; Karnell LH
    Otolaryngol Clin North Am; 1997 Feb; 30(1):113-30. PubMed ID: 8995140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of treatment of inoperable recurrences of laryngeal cancer after total laryngectomy.
    Sas-Korczyńska B; Korzeniowski S; Skolyszewski J
    Strahlenther Onkol; 1996 Feb; 172(2):99-102. PubMed ID: 8669051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant radiotherapy influences the survival of patients with squamous carcinoma of the head and neck who have poor prognoses.
    De Stefani A; Magnano M; Cavalot A; Usai A; Lerda W; Mola P; Albera R; Ragona R; Gabriele P; Bussi M; Cortesina G
    Otolaryngol Head Neck Surg; 2000 Nov; 123(5):630-6. PubMed ID: 11077354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supraglottic hemipharyngolaryngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus.
    Makeieff M; Mercante G; Jouzdani E; Garrel R; Crampette L; Guerrier B
    Head Neck; 2004 Aug; 26(8):701-5. PubMed ID: 15287037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
    Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
    Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.